Table 7.

Factors associated with following-up after a recommendation of an in-person eye exam from the POCDREP

Characteristic	Unadjusted OR	95% CI	P-value	Adjusted OR	95%CI	P-value
Age groups (18–45)	(ref)
46–55	1.15	0.81–1.63	0.45	1.14	0.75–1.74	0.54
56–65	1.19	0.85–1.66	0.32	1.39	0.91–2.12	0.13
66–75	1.17	0.82–1.66	0.38	1.77	1.10–2.85	0.02
76–97	1.18	0.78–1.78	0.42	1.45	0.80–2.62	0.21
Sex (Male)	(ref)
Female	1.13	0.92–1.37	0.24	1.23	0.95–1.61	0.12
Race (Other)	(ref)
Black	0.93	0.53–1.65	0.81	0.95	0.42–2.15	0.91
White	0.88	0.50–1.57	0.67	0.66	0.29–1.47	0.31
Married (Single)	(ref)
Married	1.33	1.07–1.64	0.009	1.38	1.03–1.84	0.03
Insurance (Other)	(ref)
Commercial	0.98	0.78–1.24	0.89	1.02	0.75–1.40	0.88
Socioeconomic status (0–9.9% Q1)	(ref)
10–19.9% (Q2)	0.88	0.69–1.11	0.28	0.92	0.68–1.26	0.62
20–29.9% (Q3)	0.76	0.48–1.18	0.22	0.67	0.38–1.20	0.18
30–39.9% (Q4)	1.00	0.64–1.56	0.99	0.74	0.39–1.38	0.34
Smoking status (Never)	(ref)
Former Smoker	0.89	0.71–1.12	0.33	0.98	0.73–1.32	0.91
Smoker	0.66	0.50–0.86	0.002	0.70	0.49–1.01	0.06
DR level (No DR)	(ref)
Mild	1.09	0.67–1.75	0.73	1.16	0.68–1.98	0.59
Moderate	1.21	0.88–1.66	0.25	1.28	0.86–1.90	0.22
Severe	2.47	1.33–4.57	0.004	2.69	1.30–5.53	0.007
Proliferative	1.55	0.81–2.96	0.19	1.75	0.83–3.73	0.14
Macular exudate	1.54	0.79–3.01	0.20	1.58	0.75–3.35	0.23
Glaucoma suspect (No)	(ref)
Yes	0.96	0.76–1.23	0.76	1.02	0.73–1.41	0.91
Time between exam and report (0 days)	(ref)
1 day	0.88	0.51–1.52	0.65	0.72	0.35–1.48	0.37
2–3 days	0.90	0.53–1.54	0.71	1.04	0.55–1.98	0.89
4–6 days	0.66	0.37–1.21	0.18	0.73	0.34–1.56	0.42
> 6 days	0.86	0.55–1.35	0.51	0.84	0.46–1.52	0.56

Legend: ref: category of reference, POCDREP Point-of-Care Diabetic Retinopathy Examination Program, DR Diabetic Retinopathy